The aim of this study was therefore to investigate the likely beneficial effects of GLP-1 in this setting, testing the hypothesis that exendin-4 modulates development and progression of adverse cardiac remodelling in experimental diabetes by specifically targeting inflammatory and ECM components. Here, GCG is linked to diabetes mellitus.